CONFIRMED: ADVERSE REACTION - CBDC

Published:  23 November 2021 Trends in ambulatory cardiology consultations for suspected myocarditis after COVID-19 vaccination Holger Eggebrecht ,  Philipp Breitbart ,  Alexander Koch ,  Bernd Nowak ,  Claudia Walther ,  Thomas Voigtländer ,  Christoph Liebetrau ,  Rajendra H. Metha  &  Axel Schmermund   In Germany, vaccination against coronavirus disease 2019 (COVID-19) was approved on December 21st 2020 and the first patient treated on December 26th. On May 7th 2021, the European Medicines Agency (EMA) announced an official investigation of case reports of myopericarditis in temporal relation to COVID-19 vaccination [ 1 , 2 , 3 ], which was updated on June 11th [ 4 ]. Since then, we noted increasing requests from General Practitioners for urgent cardiologic consultation of patients with suspected myocarditis after COVID-19 vaccination. All patients were scheduled within the 2 following business days and underwent standardized cardiologic assessment including electrocardiography

  A case of a 32-year-old woman who presented with symptoms and suggestive of multiple sclerosis (MS) a few days after receiving the 1st dose of the #CovidVaccine (Pfizer-BioNTech). Laboratory and imaging findings confirmed the diagnosis of MS. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8604537/ A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine Ariana R. Tagliaferri ,   George Horani ,   Katherine Stephens ,  and  Patrick Michael Author information   Copyright and License information   Disclaimer Go to: ABSTRACT Multiple sclerosis (MS) is an auto-immune mediated neurological disorder that affects the central nervous system and leads to myelin sheath destruction. The pathogenesis of MS involves T helper cells causing inflammation and eventual death of the oligodendrocytes. Etiologies for the development of MS include a combination of genetic, environmental, and immune factors. Vaccines have been proposed to increase the immune response and have rep

  Acute psychosis due to anti-N-methyl D-aspartate receptor encephalitis following #CovidVaccination (Pfizer-BioNTech): https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599934/ A woman in her 20's. She presented initially with anxiety & hypochondriacal delusions which progressed to psychosis & catatonia Front Neurol.  2021; 12: 764197. Published online 2021 Nov 4.  doi:  10.3389/fneur.2021.764197 PMCID:  PMC8599934 PMID:  34803896 Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report Abstract Anti-N-methyl D-aspartate (NMDA) receptor (anti-NMDAR) encephalitis has been reported after SARS-CoV-2 infection, but not after SARS-CoV-2 vaccination. We report the first known case of anti-NMDAR encephalitis after SARS-CoV-2 immunization in a young female presenting with acute psychosis, highlighting a rare potential immunological complication of vaccination against SARS-CoV-2 that is currently being distributed worldw

Artemisia annua  hot-water extracts show potent activity  in vitro  against Covid-19 variants including delta M.S.   Nair ,  Y.   Huang ,  D.A.   Fidock ,  M.J.   Towler ,  P.J.   Weathers doi:  https://doi.org/10.1101/2021.09.08.459260 Abstract Ethnopharmacological relevance  For millennia in Southeast Asia,  Artemisia annua  L. was used to treat “fever”. This medicinal plant is effective against numerous infectious microbial and viral diseases and is used by many global communities as a source of artemisinin derivatives that are first-line drugs to treat malaria. Aim of the Study  The SARS-CoV-2 (Covid-19) global pandemic has killed millions and evolved numerous variants, with delta being the most transmissible to date and causing break-through infections of vaccinated individuals. We further queried the efficacy of  A. annua  cultivars against new variants. Materials and Methods  Using Vero E6 cells, we measured anti-SARS-CoV-2 activity of dried-leaf hot-water  A. annua  extracts of